A pre-filled injectable pen designed for easy subcutaneous administration.
Contains tirzepatide, a dual GIP and GLP-1 receptor agonist.
Commonly prescribed for type 2 diabetes and weight management support.
Tirzepatide Pen
$200.00 – $300.00Price range: $200.00 through $300.00
| Weight | 0.015 lbs |
|---|---|
| Dimensions | 6.5 × 0.75 × 0.75 in |
| Dose | 2.5mg, 3.5mg, 4.5mg |
Tirzepatide Pen
A convenient pre-filled injectable pen designed for precise subcutaneous dosing. Formulated with tirzepatide, a dual GIP and GLP-1 receptor agonist. Commonly prescribed for type 2 diabetes management and weight control support.
Tirzepatide Pen
A convenient pre-filled injectable pen designed for precise subcutaneous dosing. Formulated with tirzepatide, a dual GIP and GLP-1 receptor agonist. Commonly prescribed for type 2 diabetes management and weight control support.
Tirzepatide Pen
A convenient pre-filled injectable pen designed for precise subcutaneous dosing. Formulated with tirzepatide, a dual GIP and GLP-1 receptor agonist. Commonly prescribed for type 2 diabetes management and weight control support.
Tirzepatide Pen
A convenient pre-filled injectable pen designed for precise subcutaneous dosing. Formulated with tirzepatide, a dual GIP and GLP-1 receptor agonist. Commonly prescribed for type 2 diabetes management and weight control support.
Tirzepatide Smart Pen
An advanced smart injection pen for accurate retatrutide administration. Designed for controlled and user-friendly subcutaneous delivery. Currently studied for metabolic health and weight management applications.
TIRZEPATIDE PEN
A once-weekly injectable medication for managing type 2 diabetes and promoting weight loss, by targeting GLP-1 and GIP receptors.
TIRZEPATIDE PEN
A medication designed to help regulate blood sugar levels and support weight loss, delivered via an easy-to-use pen injection.
TIRZEPATIDE PEN
A pen injection therapy for type 2 diabetes and obesity, acting on GLP-1 and GIP receptors to improve metabolic health.
TIRZEPATIDE PEN
A dual receptor agonist injection that supports blood sugar control and weight management, currently approved for use in type 2 diabetes.



